Cooper Companies Inc(COO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 20.86 | EPS (ttm) | 2.93 | Insider Own | 0.64% | Shs Outstand | 190.1M | Perf Week | 5.12% |
| Market Cap | 11.63B | Forward P/E | 13.06 | EPS next Y | 3.32% | Insider Trans | 2.93% | Shs Float | 188.9M | Perf Month | 10.4% |
| Enterprise Value | 14.02B | PEG | 1.8 | EPS next Q | 1.07 | Inst Own | 111.84% | Short Float | 4.41% | Perf Quarter | -15.15% |
| Income | 0.57B | P/S | 2.74 | EPS this Y | 9.96% | Inst Trans | 1.22% | Short Ratio | 2.51 | Perf Half Y | -4.97% |
| Sales | 4.24B | P/B | 1.4 | EPS next 5Y | 7.25% | ROA | 4.55% | Short Interest | 8.33M | Perf YTD | -25.4% |
| Book/sh | 43.81 | P/C | 75.06 | EPS past 3/5Y | -1.15% 9.3% | ROE | 6.84% | 52W High | -31.94% ($89.83) | Perf Year | -16.83% |
| Cash/sh | 0.81 | P/FCF | 17.15 | Sales past 3/5Y | 7.35% 10.98% | ROIC | 5.57% | 52W Low | 19.86% ($51.01) | Perf 3Y | -20.56% |
| Dividend Est. | - | EV/EBITDA | 11.68 | EPS Y/Y TTM | 43.89% | Gross Margin | 61.39% | Volatility(W/M) | 2.24% 2.42% | Perf 5Y | -41.29% |
| Dividend TTM | - | EV/Sales | 3.31 | Sales Y/Y TTM | 4.73% | Oper. Margin | 19.26% | ATR (14) | 1.59 | Perf 10Y | 38.8% |
| Dividend Ex-Date | 2023/7/26 | Quick Ratio | 0.73 | EPS Q/Q | 355.3% | Profit Margin | 13.46% | RSI (14) | 60.77 | Recom | 2.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.22 | Sales Q/Q | 0.56% | SMA20 | 6.82% ($57.24) | Beta | 0.83 | Target Price | $65.43 |
| Payout | - | Debt/Eq | 0.31 | Earnings | 2026/9/9 | SMA50 | -0.78% ($61.62) | Rel Volume | 0.55 | Prev Close | $61.21 |
| Employees | 15000 | LT Debt/Eq | 0.23 | EPS/Sales Surpr. | 2.34% -2.93% | SMA200 | -11.84% ($69.35) | Avg Volume(3M) | 3.32M | Price | $61.14 |
| IPO | 1983/1/21 | Option/Short | Yes/Yes | Trades | 24171 | Volume | 1,834,818 | Change | -0.11% |
A U.S. medical device company, it operates a global contact lens and women's health medical device business, combining a vision correction business centered on contact lenses with medical devices related to women's health and infertility treatment. Its pediatric myopia management lenses are growing.
Over the past 1 year, roughly in the middle
32% below its 1-year high.
Traded less than usual. That is 55% of its average volume.
COO earns at a steady pace
Of every $100 in sales, $19.26 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +10.0% this year.
Tap to view numbers
Within its industry, it looks cheap
Counting its debt, for $100 of yearly operating cash you would pay $1,168. Peers typically go for $1,583. Compared with its own 5-year average, it is 52% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -41.3%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 111.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #10 of 51 in the industry
Based on market cap of $12B.
BAX#8 Baxter International Inc $13B PER - 
AVTR#9 Avantor Inc $12B PER - COO#10 Cooper Companies Inc $12B PER 20.9 
RGEN#11 Repligen Corp $11B PER 245.6 
ALGN#12 Align Technology Inc $11B PER 26.4 
FAQ
What kind of company is COO?
COO belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of COO?
The market cap of COO is approximately $11.6B, ranking 825 within its sector.
What is the P/E ratio of COO?
COO has a P/E ratio of approximately 20.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for COO?
COO has recorded a 52-week high of $89.83 and a low of $51.01.
